FABP9 and neoplasm: Pan-cancer analysis has found that FABP9 is widely involved in tumor occurrence through key pathways such as G2/M checkpoint regulation and TP53 signaling pathway, co-expressing with cell cycle and apoptosis-related genes (e.g., CDK1, PLK1)[156].